Fig. 3

Changes of Factor and total scores in type 2 diabetes mellitus according to insulin treatment. The upper figure (a) shows the receiving multiple insulin therapy, the lower figure (b) shows the receiving BOT on type 2 patients. Grey, white, and dark columns indicate DTR-QOL score at baseline, 12 weeks, and 24 weeks, respectively. Data are mean ± SD (bars) for all assigned participants. Comparisons were made by ANOVA. ^* p < 0.05, ^** p < 0.005, significantly different from baseline